| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $17,051 | +850 | +1.8% | $20.06* | 47,100 | 28 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $103,436 | -850 | -1.8% | $121.69 | 46,250 | 28 Jan 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $51,213 | +2,553 | +5.5% | $20.06* | 48,803 | 28 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $312,564 | -2,553 | -5.2% | $122.43 | 46,250 | 28 Jan 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $17,713 | +883 | +1.9% | $20.06* | 47,133 | 28 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $108,953 | -883 | -1.9% | $123.39 | 46,250 | 28 Jan 2022 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $4,293 | +214 | +0.46% | $20.06* | 46,464 | 28 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $26,585 | -214 | -0.46% | $124.23 | 46,250 | 28 Jan 2022 | Direct | F1, F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -850 | -6.5% | $0.000000 | 12,150 | 28 Jan 2022 | Common Stock | 850 | $20.06 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2,553 | -21% | $0.000000 | 9,597 | 28 Jan 2022 | Common Stock | 2,553 | $20.06 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -883 | -9.2% | $0.000000 | 8,714 | 28 Jan 2022 | Common Stock | 883 | $20.06 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -214 | -2.5% | $0.000000 | 8,500 | 28 Jan 2022 | Common Stock | 214 | $20.06 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $120.99 to $121.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $122.03 to $122.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $123.04 to $124.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $124.13 to $124.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Options were fully vested on 5/17/13. |